search
Back to results

Irrisept C.Acnes Study

Primary Purpose

Rate of Positive Culture Growth for C.Acnes From Specimens Obtained From the Shoulders of Patients Undergoing Primary Shoulder Arthroplasty

Status
Unknown status
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Antiseptic Cleanser
Sponsored by
Orthopaedic Associates of Michigan, PC
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Rate of Positive Culture Growth for C.Acnes From Specimens Obtained From the Shoulders of Patients Undergoing Primary Shoulder Arthroplasty focused on measuring Shoulder Arthroplasty, C.acnes, Cutibacterium acnes, Irrisept

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Patient has signed the IRB-approved informed consent form specific to this study prior to undergoing any research related procedures
  2. Patient can read and understand English
  3. Patient who will undergo a primary shoulder arthroplasty
  4. Patient is over the age of 18

Exclusion Criteria:

  1. Patient who has had a previous surgery on the ipsilateral shoulder
  2. Patient has a known allergy to topical iodine or Chlorohexidine gluconate.
  3. Patient has had non-surgical prophylaxis antibiotic treatment within 14 days of index surgery
  4. Patient requires a revision procedure for a previous ipsilateral shoulder surgery
  5. Patient has any significant pathology that, in the opinion of investigator, makes the patient unsuitable for study participation
  6. Patient is a pregnant woman

Sites / Locations

  • Orthopaedic Associates of Michigan, PCRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Antiseptic Cleanser

Standard of Care Prophylaxis

Arm Description

Standard prophylaxis will be administered by Irrisept patients as would individuals in the control group. In addition, these Irrisept study subjects will be supplemented with the use of Irrisept irrigation by the study surgeon during the patient's surgical procedure. Standard times for irrigation will include immediately after incision through the dermal layer, and immediately prior to implantation of any prosthetic components. Final irrigation will be performed just prior to closure of the deltopectoral interval.

Standard prophylaxis includes use of chlorhexidine wipes (Sage cloth) the night before and morning of surgery on the surgical site over the anterior shoulder.

Outcomes

Primary Outcome Measures

C.acnes Growth Rate
To compare the rate of C.acnes using two different antiseptic protocols

Secondary Outcome Measures

Visual Analog Scale (VAS)
Assessment of clinical/subjective feedback via questionnaires during the postoperative follow up period. VAS assessment: [0 (no pain) - 10 (worse possible pain)]
ROM
Range of Motion
American Shoulder and Elbow Surgeons Shoulder Score (ASES)
the Society of the American Shoulder and Elbow Surgeons to facilitate standardization of outcome measures.

Full Information

First Posted
May 2, 2019
Last Updated
May 20, 2021
Sponsor
Orthopaedic Associates of Michigan, PC
Collaborators
Mercy Health
search

1. Study Identification

Unique Protocol Identification Number
NCT03938467
Brief Title
Irrisept C.Acnes Study
Official Title
Effect of Antiseptic Irrigation With 0.05% Chlorhexidine Gluconate (Irrisept) on Incidence of Cutibacterium Acnes in Shoulder Arthroplasty
Study Type
Interventional

2. Study Status

Record Verification Date
May 2021
Overall Recruitment Status
Unknown status
Study Start Date
March 1, 2021 (Actual)
Primary Completion Date
October 1, 2023 (Anticipated)
Study Completion Date
October 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Orthopaedic Associates of Michigan, PC
Collaborators
Mercy Health

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
A Prospective, Randomized, Controlled Trial Comparing An Irrisept Antiseptic Irrigation With 0.05% Chlorhexidine Gluconate versus Standard of Care Prophylaxis Chlorohexidine Wipes
Detailed Description
The purpose of this prospective randomized control trial is to access outcomes of positive culture growth of C. acnes from specimens obtained from the shoulders of patients undergoing primary shoulder arthroplasty whose intraoperative management includes Irrisept antiseptic irrigation and compare it to patients whose management includes standard of care prophylaxis wipes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rate of Positive Culture Growth for C.Acnes From Specimens Obtained From the Shoulders of Patients Undergoing Primary Shoulder Arthroplasty
Keywords
Shoulder Arthroplasty, C.acnes, Cutibacterium acnes, Irrisept

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
Prospective, Randomized, Controlled Trial
Masking
Participant
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Antiseptic Cleanser
Arm Type
Experimental
Arm Description
Standard prophylaxis will be administered by Irrisept patients as would individuals in the control group. In addition, these Irrisept study subjects will be supplemented with the use of Irrisept irrigation by the study surgeon during the patient's surgical procedure. Standard times for irrigation will include immediately after incision through the dermal layer, and immediately prior to implantation of any prosthetic components. Final irrigation will be performed just prior to closure of the deltopectoral interval.
Arm Title
Standard of Care Prophylaxis
Arm Type
No Intervention
Arm Description
Standard prophylaxis includes use of chlorhexidine wipes (Sage cloth) the night before and morning of surgery on the surgical site over the anterior shoulder.
Intervention Type
Drug
Intervention Name(s)
Antiseptic Cleanser
Other Intervention Name(s)
Irrisept Wound Cleansing System
Intervention Description
Contains 0.05% Chlorhexidine gluconate in sterile water for irrigation. The mechanical action of the Irrisept system removes bacteria and debris without harming underlying tissues. Irrisept has demonstrated broad spectrum bactericidal activity against antibiotic-resistant strains. Its contents are wrapped in two sequential sterilization wraps which repel water blood, and saline, making it effective against both air and water borne bacteria.
Primary Outcome Measure Information:
Title
C.acnes Growth Rate
Description
To compare the rate of C.acnes using two different antiseptic protocols
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Visual Analog Scale (VAS)
Description
Assessment of clinical/subjective feedback via questionnaires during the postoperative follow up period. VAS assessment: [0 (no pain) - 10 (worse possible pain)]
Time Frame
6 months
Title
ROM
Description
Range of Motion
Time Frame
6 Months
Title
American Shoulder and Elbow Surgeons Shoulder Score (ASES)
Description
the Society of the American Shoulder and Elbow Surgeons to facilitate standardization of outcome measures.
Time Frame
6 Months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patient has signed the IRB-approved informed consent form specific to this study prior to undergoing any research related procedures Patient can read and understand English Patient who will undergo a primary shoulder arthroplasty Patient is over the age of 18 Exclusion Criteria: Patient who has had a previous surgery on the ipsilateral shoulder Patient has a known allergy to topical iodine or Chlorohexidine gluconate. Patient has had non-surgical prophylaxis antibiotic treatment within 14 days of index surgery Patient requires a revision procedure for a previous ipsilateral shoulder surgery Patient has any significant pathology that, in the opinion of investigator, makes the patient unsuitable for study participation Patient is a pregnant woman
Facility Information:
Facility Name
Orthopaedic Associates of Michigan, PC
City
Grand Rapids
State/Province
Michigan
ZIP/Postal Code
49525
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michelle A Padley, MS
Phone
616-459-7101
Ext
1797
Email
michelle.padley@oamichigan.com
First Name & Middle Initial & Last Name & Degree
Daisy Gomez De Leon, BS
Phone
616-459-7101
Ext
2021
Email
Daisy.GomezDeLeon@oamichigan.com
First Name & Middle Initial & Last Name & Degree
Tim R Lenters, MD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
25979553
Citation
Horneff JG 3rd, Hsu JE, Voleti PB, O'Donnell J, Huffman GR. Propionibacterium acnes infection in shoulder arthroscopy patients with postoperative pain. J Shoulder Elbow Surg. 2015 Jun;24(6):838-43. doi: 10.1016/j.jse.2015.03.008.
Results Reference
background
PubMed Identifier
22981447
Citation
Levy O, Iyer S, Atoun E, Peter N, Hous N, Cash D, Musa F, Narvani AA. Propionibacterium acnes: an underestimated etiology in the pathogenesis of osteoarthritis? J Shoulder Elbow Surg. 2013 Apr;22(4):505-11. doi: 10.1016/j.jse.2012.07.007. Epub 2012 Sep 13.
Results Reference
background
PubMed Identifier
24306704
Citation
Matsen FA 3rd, Butler-Wu S, Carofino BC, Jette JL, Bertelsen A, Bumgarner R. Origin of propionibacterium in surgical wounds and evidence-based approach for culturing propionibacterium from surgical sites. J Bone Joint Surg Am. 2013 Dec 4;95(23):e1811-7. doi: 10.2106/JBJS.L.01733.
Results Reference
background
PubMed Identifier
25547858
Citation
Matsen FA 3rd, Russ SM, Bertelsen A, Butler-Wu S, Pottinger PS. Propionibacterium can be isolated from deep cultures obtained at primary arthroplasty despite intravenous antimicrobial prophylaxis. J Shoulder Elbow Surg. 2015 Jun;24(6):844-7. doi: 10.1016/j.jse.2014.10.016. Epub 2014 Dec 26.
Results Reference
background
PubMed Identifier
26085528
Citation
Mook WR, Klement MR, Green CL, Hazen KC, Garrigues GE. The Incidence of Propionibacterium acnes in Open Shoulder Surgery: A Controlled Diagnostic Study. J Bone Joint Surg Am. 2015 Jun 17;97(12):957-63. doi: 10.2106/JBJS.N.00784.
Results Reference
background
PubMed Identifier
25483906
Citation
Sethi PM, Sabetta JR, Stuek SJ, Horine SV, Vadasdi KB, Greene RT, Cunningham JG, Miller SR. Presence of Propionibacterium acnes in primary shoulder arthroscopy: results of aspiration and tissue cultures. J Shoulder Elbow Surg. 2015 May;24(5):796-803. doi: 10.1016/j.jse.2014.09.042. Epub 2014 Dec 4.
Results Reference
background
PubMed Identifier
26067191
Citation
Sabetta JR, Rana VP, Vadasdi KB, Greene RT, Cunningham JG, Miller SR, Sethi PM. Efficacy of topical benzoyl peroxide on the reduction of Propionibacterium acnes during shoulder surgery. J Shoulder Elbow Surg. 2015 Jul;24(7):995-1004. doi: 10.1016/j.jse.2015.04.003.
Results Reference
background

Learn more about this trial

Irrisept C.Acnes Study

We'll reach out to this number within 24 hrs